80_FR_38843 80 FR 38714 - Submission for OMB Review; 30-Day Comment Request; Generic Clearance To Conduct Voluntary Customer/Partner Surveys (NLM) [email protected] or by fax to 202-395-6974, Attention: NIH Desk Officer. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication."> [email protected] or by fax to 202-395-6974, Attention: NIH Desk Officer. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication." /> [email protected] or by fax to 202-395-6974, Attention: NIH Desk Officer. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication." />

80 FR 38714 - Submission for OMB Review; 30-Day Comment Request; Generic Clearance To Conduct Voluntary Customer/Partner Surveys (NLM)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 129 (July 7, 2015)

Page Range38714-38715
FR Document2015-16633

Under the provisions of section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. This proposed information collection was previously published in the Federal Register on April 22, 2015, page 22542 and allowed 60-days for public comment. One public comment was received. The purpose of this notice is to allow an additional 30 days for public comment. The National Library of Medicine (NLM), National Institutes of Health, may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number. Direct Comments to OMB: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the: Office of Management and Budget, Office of Regulatory Affairs, [email protected] or by fax to 202-395-6974, Attention: NIH Desk Officer. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication.

Federal Register, Volume 80 Issue 129 (Tuesday, July 7, 2015) 
[Federal Register Volume 80, Number 129 (Tuesday, July 7, 2015)]
[Notices]
[Pages 38714-38715]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-16633]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Submission for OMB Review; 30-Day Comment Request; Generic 
Clearance To Conduct Voluntary Customer/Partner Surveys (NLM)

SUMMARY: Under the provisions of section 3507(a)(1)(D) of the Paperwork 
Reduction Act of 1995, the National Institutes of Health (NIH) has 
submitted to the Office of Management and Budget

[[Page 38715]]

(OMB) a request for review and approval of the information collection 
listed below. This proposed information collection was previously 
published in the Federal Register on April 22, 2015, page 22542 and 
allowed 60-days for public comment. One public comment was received. 
The purpose of this notice is to allow an additional 30 days for public 
comment. The National Library of Medicine (NLM), National Institutes of 
Health, may not conduct or sponsor, and the respondent is not required 
to respond to, an information collection that has been extended, 
revised, or implemented on or after October 1, 1995, unless it displays 
a currently valid OMB control number.
    Direct Comments to OMB: Written comments and/or suggestions 
regarding the item(s) contained in this notice, especially regarding 
the estimated public burden and associated response time, should be 
directed to the: Office of Management and Budget, Office of Regulatory 
Affairs, [email protected] or by fax to 202-395-6974, 
Attention: NIH Desk Officer.
    Comment Due Date: Comments regarding this information collection 
are best assured of having their full effect if received within 30-days 
of the date of this publication.

FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data 
collection plans and instruments or request more information on the 
proposed project contact: David Sharlip, Office of Administrative and 
Management Analysis Services, National Library of Medicine, Building 
38A, Room B2N12, 8600 Rockville Pike, Bethesda, MD 20894, or call non-
toll-free number (301) 402-9680, or Email your request, including your 
address to: [email protected] Formal requests for additional plans 
and instruments must be requested in writing.
    Proposed Collection: Generic Clearance to Conduct Voluntary 
Customer/Partner Surveys (NLM), 0925-0476, Expiration Date 07/31/2015, 
EXTENSION, National Library of Medicine (NLM), National Institutes of 
Health (NIH).
    Need and Use of Information Collection: E.O. 12962 directed 
agencies that provide significant services directly to the public to 
survey customers to determine the kind and quality of services they 
want and their level of satisfaction with existing services. 
Additionally, since 1994, the NLM has been a ``Federal Reinvention 
Laboratory'' with a goal of improving its methods of delivering 
information to the public. An essential strategy in accomplishing 
reinvention goals is the ability to periodically receive input and 
feedback from customers about the design and quality of the services 
they receive. The NLM provides significant services directly to the 
public including health providers, researchers, universities, other 
federal agencies, state and local governments, and to others through a 
range of mechanisms, including publications, technical assistance, and 
Web sites. These services are primarily focused on health and medical 
information dissemination activities. The purpose of this submission is 
to obtain OMB's generic approval to continue to conduct satisfaction 
surveys of NLM's customers. The NLM will use the information provided 
by individuals and institutions to identify strengths and weaknesses in 
current services and to make improvements where feasible. The ability 
to periodically survey NLM's customers is essential to continually 
update and upgrade methods of providing high quality service.
    OMB approval is requested for 3 years. There are no costs to 
respondents other than their time. The total estimated annualized 
burden hours are 750.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                   Average time
               Type of respondents                   Number of     Frequency of    per response    Total burden
                                                    respondents      response     (minutes/hour)       hours
----------------------------------------------------------------------------------------------------------------
General Public..................................           1,000               1           20/60             333
Health Professionals............................             500               1           15/60             125
Librarians......................................             500               1           20/60             167
Health Educators................................             500               1           15/60             125
----------------------------------------------------------------------------------------------------------------


    Dated: June 29, 2015.
David Sharlip,
Project Clearance Liaison, NLM, NIH.
[FR Doc. 2015-16633 Filed 7-6-15; 8:45 am]
BILLING CODE 4140-01-P

38714 Federal Register / Vol. 80, No. 129 / Tuesday, July 7, 2015 / Notices Boulevard, Bethesda, MD 20892 (Telephone SUMMARY: This is notice, in accordance SUPPLEMENTARY INFORMATION: This Conference Call). with 35 U.S.C. 209 and 37 CFR part 404, technology, and its corresponding Contact Person: Maria E. Davila-Bloom, that the National Institutes of Health, patent applications, is directed to Ph.D., Scientific Review Officer, Review Department of Health and Human methods of treating or preventing spinal Branch, DEA, NIDDK, National Institutes of Health, Room 758, 6707 Democracy Services, is contemplating the grant of cord injury or a glial scar by Boulevard, Bethesda, MD 20892–5452, (301) an exclusive patent license to practice administering an agent that reduces the 594–7637, davila-bloomm@ the following inventions embodied in amount or activity of a 4-sulfacted extra.niddk.nih.gov. the following patent applications: GalNAc in a chondroitin Name of Committee: National Institute of HHS Ref. No.: E–214–2012/0 glycosaminoglycan chain, wherein said Diabetes and Digestive and Kidney Diseases Titled: ‘‘Compositions and Methods for the agent includes human enzyme, Special Emphasis Panel; T2D Outcomes Treatment of Central Nervous System arylsulfatase B (ARSB). This technology, Ancillary Study. Injury’’ and its corresponding patent Date: August 6, 2015. 1. US Provisional Patent Application No.: applications, is also directed to methods Time: 11:00 a.m. to 1:00 p.m. 61/705,555 HHS Ref. No.: E–214–2012/ of increasing neuron growth, Agenda: To review and evaluate grant 0–US–01 Filing Date: September 25, applications. proliferation, or migration by 2012 administering an agent that reduces the Place: National Institutes of Health, Two 2. PCT Patent Application No.: PCT/ Democracy Plaza, 6707 Democracy amount or activity of a 4-sulfacted US2013/061693 HHS Ref. No.: E–214– Boulevard, Bethesda, MD 20892 (Telephone 2012/0–PCT–02 Filing Date: September GalNAc in a chondroitin Conference Call). 25, 2013 glycosaminoglycan chain, wherein said Contact Person: Robert Wellner, Ph.D., 3. Australian Patent Application No.: agent includes ARSB. This technology Scientific Review Officer, Review Branch, 2013–32367 HHS Ref No.: E–214–2012/ may be useful as a means to treat DEA, NIDDK, National Institutes of Health, 0–AU–03 Filing Date: September 25, paralysis and motor defects induced by Room 706, 6707 Democracy Boulevard, 2013 Bethesda, MD 20892–5452, 301–594–4721, spinal cord injury, such as by promoting 4. European Patent Application No.: axonal regrowth. rw175w@nih.gov. 13771750 HHS Ref. No.: E–214–2012/0– The prospective exclusive license will Name of Committee: National Institute of EP–04 Filing Date: September 25, 2013 Diabetes and Digestive and Kidney Diseases be royalty bearing and will comply with 5. U.S. Patent Application No.: 14/430,850 Special Emphasis Panel; Reengineering HHS Ref. No.: E–214–2012/0–US–06 the terms and conditions of 35 U.S.C. Organs P01. Filing Date: September 25, 2013 209 and 37 CFR part 404. The Date: August 10, 2015. prospective exclusive license may be Time: 11:00 a.m. to 1:00 p.m. to BioAxone Biosciences Incorporated granted unless within thirty (30) days Agenda: To review and evaluate grant (‘‘BioAxone’’), a company incorporated from the date of this published notice, applications. under the laws of the State of Delaware the NIH receives written evidence and Place: National Institutes of Health, Two having an office in at least Cambridge, argument that establishes that the grant Democracy Plaza, 6707 Democracy Massachusetts, U.S.A. The patent rights Boulevard, Bethesda, MD 20892 (Telephone of the license would not be consistent in these inventions have been assigned with the requirements of 35 U.S.C. 209 Conference Call). Contact Person: Thomas A. Tatham, Ph.D., to the United States of America. and 37 CFR part 404. Scientific Review Officer, Review Branch, BioAxone is seeking all worldwide Properly filed competing applications DEA, NIDDK, National Institutes of Health, territories for this license. The field of for a license in response to this notice Room 760, 6707 Democracy Boulevard, use may be limited to ‘‘Treatment of will be treated as objections to the Bethesda, MD 20892–5452, (301) 594–3993, human acute and chronic neurological contemplated license. Comments and tathamt@mail.nih.gov. injuries involving axonal regeneration, objections submitted in response to this (Catalogue of Federal Domestic Assistance as monotherapy or in combination with notice will not be made available for Program Nos. 93.847, Diabetes, other therapeutic drugs or medical public inspection and, to the extent Endocrinology and Metabolic Research; devices’’. permitted by law, will not be released 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology DATES: Only written comments and/or under the Freedom of Information Act, and Hematology Research, National Institutes applications for a license which are 5 U.S.C. 552. of Health, HHS) received by the NIH Office of Dated: June 30, 2015. Dated: June 30, 2015. Technology Transfer on or before Richard U. Rodriguez, David Clary, August 6, 2015 will be considered. Acting Director, Office of Technology Program Analyst, Office of Federal Advisory ADDRESSES: Requests for copies of the Transfer, National Institutes of Health. Committee Policy. patent application, patents, inquiries, [FR Doc. 2015–16500 Filed 7–6–15; 8:45 am] [FR Doc. 2015–16503 Filed 7–6–15; 8:45 am] comments, and other materials relating BILLING CODE 4140–01–P BILLING CODE 4140–01–P to the contemplated exclusive license should be directed to: Cristina Thalhammer-Reyero, Ph.D., M.B.A., DEPARTMENT OF HEALTH AND DEPARTMENT OF HEALTH AND Office of Technology Transfer, National HUMAN SERVICES HUMAN SERVICES Institutes of Health, 6011 Executive Boulevard, Suite 325, Rockville, MD National Institutes of Health National Institutes of Health 20852–3804; Telephone: (301) 435– Submission for OMB Review; 30-Day 4507; Facsimile: (301) 402–0220; Email: Prospective Grant of Exclusive Comment Request; Generic Clearance thalhamc@mail.nih.gov. A signed To Conduct Voluntary Customer/ tkelley on DSK3SPTVN1PROD with NOTICES License: Treatment of Acute and confidentiality nondisclosure agreement Chronic Neurological Injuries Involving Partner Surveys (NLM) will be required to receive copies of any Axonal Regeneration patent applications or patents that have SUMMARY: Under the provisions of AGENCY: National Institutes of Health, not been published or issued by the section 3507(a)(1)(D) of the Paperwork HHS. United States Patent and Trademark Reduction Act of 1995, the National Office or the World Intellectual Property Institutes of Health (NIH) has submitted ACTION: Notice. Organization. to the Office of Management and Budget VerDate Sep<11>2014 20:31 Jul 06, 2015 Jkt 235001 PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 E:\FR\FM\07JYN1.SGM 07JYN1

Federal Register / Vol. 80, No. 129 / Tuesday, July 7, 2015 / Notices 38715 (OMB) a request for review and FOR FURTHER INFORMATION CONTACT: To public. An essential strategy in approval of the information collection obtain a copy of the data collection accomplishing reinvention goals is the listed below. This proposed information plans and instruments or request more ability to periodically receive input and collection was previously published in information on the proposed project feedback from customers about the the Federal Register on April 22, 2015, contact: David Sharlip, Office of design and quality of the services they page 22542 and allowed 60-days for Administrative and Management receive. The NLM provides significant public comment. One public comment Analysis Services, National Library of services directly to the public including was received. The purpose of this notice Medicine, Building 38A, Room B2N12, health providers, researchers, is to allow an additional 30 days for 8600 Rockville Pike, Bethesda, MD universities, other federal agencies, state public comment. The National Library 20894, or call non-toll-free number (301) and local governments, and to others of Medicine (NLM), National Institutes 402–9680, or Email your request, through a range of mechanisms, of Health, may not conduct or sponsor, including your address to: sharlipd@ including publications, technical and the respondent is not required to mail.nih.gov Formal requests for assistance, and Web sites. These respond to, an information collection additional plans and instruments must services are primarily focused on health that has been extended, revised, or be requested in writing. and medical information dissemination implemented on or after October 1, Proposed Collection: Generic activities. The purpose of this 1995, unless it displays a currently valid Clearance to Conduct Voluntary submission is to obtain OMB’s generic OMB control number. Customer/Partner Surveys (NLM), 0925– approval to continue to conduct Direct Comments to OMB: Written 0476, Expiration Date 07/31/2015, satisfaction surveys of NLM’s comments and/or suggestions regarding EXTENSION, National Library of customers. The NLM will use the the item(s) contained in this notice, Medicine (NLM), National Institutes of information provided by individuals especially regarding the estimated Health (NIH). and institutions to identify strengths public burden and associated response Need and Use of Information and weaknesses in current services and time, should be directed to the: Office Collection: E.O. 12962 directed agencies to make improvements where feasible. of Management and Budget, Office of that provide significant services directly The ability to periodically survey NLM’s Regulatory Affairs, OIRA_submission@ to the public to survey customers to customers is essential to continually omb.eop.gov or by fax to 202–395–6974, determine the kind and quality of update and upgrade methods of Attention: NIH Desk Officer. services they want and their level of providing high quality service. Comment Due Date: Comments satisfaction with existing services. OMB approval is requested for 3 regarding this information collection are Additionally, since 1994, the NLM has years. There are no costs to respondents best assured of having their full effect if been a ‘‘Federal Reinvention other than their time. The total received within 30-days of the date of Laboratory’’ with a goal of improving its estimated annualized burden hours are this publication. methods of delivering information to the 750. ESTIMATED ANNUALIZED BURDEN HOURS Average time Number of Frequency of Total burden Type of respondents per response respondents response hours (minutes/hour) General Public ................................................................................................. 1,000 1 20/60 333 Health Professionals ........................................................................................ 500 1 15/60 125 Librarians ......................................................................................................... 500 1 20/60 167 Health Educators ............................................................................................. 500 1 15/60 125 Dated: June 29, 2015. and 552b(c)(6), Title 5 U.S.C., as Development, NIH, 6100 Executive David Sharlip, amended. The grant applications and Boulevard, Room 5B01, Bethesda, MD Project Clearance Liaison, NLM, NIH. the discussions could disclose 20892–9304, (301) 451–3415, duperes@ [FR Doc. 2015–16633 Filed 7–6–15; 8:45 am] confidential trade secrets or commercial mail.nih.gov. BILLING CODE 4140–01–P property such as patentable material, (Catalogue of Federal Domestic Assistance and personal information concerning Program Nos. 93.864, Population Research; individuals associated with the grant 93.865, Research for Mothers and Children; DEPARTMENT OF HEALTH AND applications, the disclosure of which 93.929, Center for Medical Rehabilitation HUMAN SERVICES would constitute a clearly unwarranted Research; 93.209, Contraception and invasion of personal privacy. Infertility Loan Repayment Program, National National Institutes of Health Name of Committee: National Institute of Institutes of Health, HHS) Child Health and Human Development Eunice Kennedy Shriver National Dated: June 30, 2015. Special Emphasis Panel. Institute of Child Health and Human Date: August 7, 2015. Michelle Trout, Development; Notice of Closed Time: 2:00 p.m. to 6:00 p.m. Program Analyst, Office of Federal Advisory Meeting Agenda: To review and evaluate grant Committee Policy. applications. tkelley on DSK3SPTVN1PROD with NOTICES Pursuant to section 10(d) of the [FR Doc. 2015–16528 Filed 7–6–15; 8:45 am] Place: National Institutes of Health, 6100 Federal Advisory Committee Act, as Executive Boulevard, Rockville, MD 20852, BILLING CODE 4140–01–P amended (5 U.S.C. App.), notice is (Telephone Conference Call). hereby given of the following meeting. Contact Person: Sherry L. Dupere, Ph.D., The meeting will be closed to the Scientific Review Officer, Scientific Review public in accordance with the Branch, Eunice Kennedy Shriver National provisions set forth in section 552b(c)(4) Institute of Child Health and Human VerDate Sep<11>2014 20:31 Jul 06, 2015 Jkt 235001 PO 00000 Frm 00055 Fmt 4703 Sfmt 9990 E:\FR\FM\07JYN1.SGM 07JYN1


Document Created: 2015-12-15 13:27:06
Document Modified: 2015-12-15 13:27:06
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesComments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication.
ContactTo obtain a copy of the data collection plans and instruments or request more information on the proposed project contact: David Sharlip, Office of Administrative and Management Analysis Services, National Library of Medicine, Building 38A, Room B2N12, 8600 Rockville Pike, Bethesda, MD 20894, or call non- toll-free number (301) 402-9680, or Email your request, including your
FR Citation80 FR 38714 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR